Formulation |
The MYL7 solution (0.5mg/1ml) contains 20mM Tris-HCl buffer (pH 8.0), 100mM NaCl, 1mM DTT and 20% glycerol. |
Purity |
Greater than 90% as determined by SDS-PAGE. |
Description |
MYL7 Human Recombinant produced in E. coli is a single polypeptide chain containing 199 amino acids (1-175) and having a molecular mass of 22.0kDa.MYL7 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
Protein Background |
MYL7 protein is an atrial isoform of myosin regulatory light chain 2 (MYL2). Myosin is a hexamer containing 4 light chains and 2 heavy chains. MYL7 is mainly expressed in adult atrial muscle. |
Expression host |
E.coli. |
Synonyms |
Myosin light chain 7 regulatory, myosin light polypeptide 7 regulatory, Myosin light chain 2a myosin regulatory light chain 2 atrial isoform, MYL2A, MYLC2A. |
Reagent Appearance |
Sterile Filtered colorless solution. |
Stability |
Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles. |
Amino acid sequence |
MGSSHHHHHH SSGLVPRGSH MGSHMASRKA GTRGKVAATK QAQRGSSNVF SMFEQAQIQE FKEAFSCIDQ NRDGIICKAD LRETYSQLGK VSVPEEELDA MLQEGKGPIN FTVFLTLFGE KLNGTDPEEA ILSAFRMFDP SGKGVVNKDE FKQLLLTQAD KFSPAEVEQM FALTPMDLAG NIDYKSLCYI ITHGDEKEE |